echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Flunarizine Hydrochloride Capsules, a wholly-owned subsidiary of Zhendong Pharmaceutical, passed the consistency evaluation of generic drugs

    Flunarizine Hydrochloride Capsules, a wholly-owned subsidiary of Zhendong Pharmaceutical, passed the consistency evaluation of generic drugs

    • Last Update: 2022-01-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On the morning of January 14, Zhendong Pharmaceutical announced that its wholly-owned subsidiary Anxin Bio had received the "Approval Notice for Supplementary Drug Application" issued by the State Drug Administration, and that Flunarizine Hydrochloride Capsules had been approved as a generic drug.


    Flunarizine hydrochloride is a selective calcium antagonist, which can block excess calcium ions from transmembrane into cells, prevent excessive intracellular calcium load, and prevent a large amount of calcium from entering neurons during ischemia and hypoxia, improving brain microcirculation And neuron metabolism, inhibit cerebral vasospasm, platelet coagulation and blood viscosity increase, etc.


    According to the data from Minet.


    Flunarizine capsule companies passed the consistency evaluation, including Shandong Fangming Pharmaceutical Group Co.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.